Merck asks the FDA for emergency authorization of its experimental Covid-19 pill.
An antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushing caseload on U.S. hospitals and helping to curb outbreaks in poorer countries with weak health care systems. It would also bolster the two-pronged approach to the pandemic: treatment, by way of medication, and prevention, primarily through vaccinations.
“The value here is that it’s a pill so you don’t have to deal with the infusion centers and all the factors around that,” said Dr. Nicholas Kartsonis, a senior vice president with Merck's infectious disease unit. “I think it's a very powerful tool to add to the toolbox.” U.S. officials continue to push vaccinations as the best way to protect against Covid-19. But with some 68 million eligible Americans still unwilling to get the shots, effective drugs will be critical to controlling future waves of infection.
Assuming FDA authorization, the U.S. government has agreed to buy enough of the pills to treat 1.7 million people, at a price of roughly $700 for each course of treatment. That's less than half the price of the antibody drugs purchased by the U.S. government — over $2,000 per infusion — but still more expensive than many antiviral pills for other conditions.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravirMerck said it is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.
Lire la suite »
Covid-19: Three more Covid-related deaths and 1,115 new casesThe total number of coronavirus-linked deaths in NI since the start of the pandemic is 2,588.
Lire la suite »
Merck asks US FDA to authorize promising anti-COVID pillWASHINGTON (AP) — Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.
Lire la suite »
Merck Asks FDA To Authorize Promising Anti-COVID PillAn antiviral pill that people could take at home to speed recovery could prove groundbreaking, easing the crushing caseload on U.S. hospitals.
Lire la suite »